Forward Citations = 0

Loading Chart...

4 inventors (with patents filed for the assignee):

Tomoichiro Asano (2 out of 5 patents)

Yusuke Nakatsu (2 out of 5 patents)

Hisanaka Ito (2 out of 5 patents)

4. Takayoshi Okabe (2 out of 9 patents)

2 patents: Sort by Forward Citations

1. 12545643 - 3,5-diaminobenzoic acid compound, and Pin1 inhibitor and therapeutic agent for inflammatory diseases using same (2026-02-10),

2. 12357626 - Anthranilic acid-based compound, and Pin1 inhibitor, therapeutic agent for inflammatory diseases and therapeutic agent for cancer that use the same (2025-07-15),

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

2 Patents

#1,303 in Seoul

#3,796 in South Korea

Seoul, South Korea

Amenis Bioscience, Inc.

Forward Citations = 0

4 inventors:

Tomoichiro Asano (2 out of 5 patents)

Yusuke Nakatsu (2 out of 5 patents)

Hisanaka Ito (2 out of 5 patents)

4. Takayoshi Okabe (2 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Amenis Bioscience, Inc.. Retrieved from https://idiyas.com/company/amenis-bioscience

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]